logo
Select company
Select metric
$ -96.29MConsolidated Income
VS
Market
12
Sector
23
Industry
32
History
29
$ 3.23Close
$ 0.88 - $ 4.74 52-Week Range
Ticker Information

Ticker

PYXS

Company Name

PYXIS ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PYXIS ONCOLOGY INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PYXS - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -96.29M
3/31/2025$ -95.23M
12/31/2024$ -77.33M
9/30/2024$ -57.36M
6/30/2024$ -59.2M
3/31/2024$ -57.8M
12/31/2023$ -73.79M
9/30/2023$ -94.29M
6/30/2023$ -98.92M
3/31/2023$ -108.58M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PYXIS ONCOLOGY INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -12.83M.
  • Over the past 5 years, PYXIS ONCOLOGY INC's average Cons. Inc. has been $ -81.18M.
  • The median Cons. Inc. for PYXIS ONCOLOGY INC during this period was $ -87.95M
  • PYXIS ONCOLOGY INC reached its highest Cons. Inc. over the past 5 years at $ -12.83M.
  • The lowest Cons. Inc. recorded by PYXIS ONCOLOGY INC in the same timeframe $ -120.72M

PYXIS ONCOLOGY INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
NTRB : NUTRIBAND INC $ -10.27MALGS : ALIGOS THERAPEUTICS INC $ -74.18MSTTK : SHATTUCK LABS INC $ -61.51MORMP : ORAMED PHARMACEUTICALS INC $ -24.22MCAMP : CAMP4 THERAPEUTICS CORP $ -51.78MARMP : ARMATA PHARMACEUTICALS INC $ -25.71MDTIL : PRECISION BIOSCIENCES INC $ -78.25MNRXS : NEURAXIS INC $ -7.17MCBUS : CIBUS INC $ -303.21MABVC : ABVC BIOPHARMA INC $ -3.28M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

PYXS - Consolidated Income, Last 5 years

$ -120.72M

Minimum

Dec 31, 2022

$ -12.83M

Maximum

Dec 31, 2020

$ -81.18M

Average

$ -87.95M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.08M with a standard deviation of $ 116.5M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.08M
median$ -2.07M
std$ 116.5M